SCA
LFCR icon

Secor Capital Advisors’s Lifecore Biomedical LFCR Stock Holding History

Secor Capital Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-33,785
Closed -$414K – 422
2014
Q3 		$414K Buy
+33,785
New +$422K 0.24% 161

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Secor Capital Advisors's LFCR Position: Q4 2014 in Review

Secor Capital Advisors sold out of Lifecore Biomedical (LFCR) in Q4 2014, closing a stake of 33,785 shares — an estimated $414K sold.

Secor Capital Advisors first reported a position in LFCR in Q3 2014 and held it in 1 quarter. The position peaked at $414K in Q3 2014. 109 funds tracked by Wall St. Rank hold LFCR as of Q4 2014.

  • Secor Capital Advisors reported no remaining Lifecore Biomedical position as of Q4 2014 after selling out during the quarter.
  • Secor Capital Advisors sold 33,785 Lifecore Biomedical shares in Q4 2014, an estimated $414K.
  • Secor Capital Advisors first reported a position in Lifecore Biomedical in Q3 2014 and held it in 1 quarter.
  • Secor Capital Advisors's Lifecore Biomedical position peaked at $414K in Q3 2014.
  • 109 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2014.

Based on Secor Capital Advisors's 13F filing for Q4 2014, filed 30 Jan 2015.